Comparison of intra-articular steroid injection with combined oral steroid and intra-articular steroid injection to treat patients with knee osteoarthritis

Farah Mahboob; Sarah  Razzaq; Ijaz  Ahmad; Maimoona  Rashid; Umer  Younus; Syed Hussain  Shah

doi:10.51253/pafmj.v75i1.11526

Authors

Farah Mahboob Department of Rehabilitation Medicine, Combined Military Hospital Kharian /National University of Medical Sciences (NUMS) Pakistan
Sarah Razzaq Department of Rehabilitation Medicine, Combined Military Hospital Mangla /National University of Medical Sciences (NUMS) Pakistan
Ijaz Ahmad Department of Rehabilitation Medicine, Combined Military Hospital Quetta /National University of Medical Sciences (NUMS) Pakistan
Maimoona Rashid Department of Rehabilitation Medicine, Combined Military Hospital Rawalpindi /National University of Medical Sciences (NUMS) Pakistan
Umer Younus Department of Rehabilitation Medicine, Combined Military Hospital Hyderabad /National University of Medical Sciences (NUMS) Pakistan
Syed Hussain Shah Department of Rehabilitation Medicine, Combined Military Hospital Muzzafarabad /National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v75i1.11526

Keywords:

Methylprednisolone, Osteoarthritis, Prednisolone.

Abstract

Objective: To evaluate the benefits provided by a short course of low dose oral Prednisolone followed by intra-articular injection of Methylprednisolone to treat osteoarthritis Knee as compared to intra-articular injection of Methylprednisolone and placebo.

Study Design: Quasi-experimental study

Place and Duration of Study: Department of Rehabilitation Medicine, Combined Military Hospital Quetta, Pakistan from Aug to Nov 2023.

Methodology: Ninety nine patients with OA of Knee joint were randomly assigned to 3 groups, Group-A received a short course (14 days) of low dose oral steroids (15 mg Prednisolone ) followed by one intra-articular steroid injection (administered two weeks later). Patients in Group-B received intra-articular injection of steroid only and Group-C received intra-articular injection of normal saline. All patients were evaluated using the Western Ontario and McMaster Universities (WOMAC) & Visual Analogue Scale (VAS) score before the treatment and at 2,6,12 and 16 weeks following treatment.

Result: There were significant improvements in both Group-A & Group-B. Particularly, patients in Group-A had significantly superior VAS and WOMAC scores than were seen in groups B and C. The VAS and WOMAC scores remained the same as were pre-treatment in group C. Group-A and B both showed improvement but to different extent with superior results in Group-A till 16 weeks.

Conclusion: The combination of short course of low dose oral steroids with intra-articular steroid injections resulted in significantly superior symptomatic improvement, with sustained lower VAS and WOMAC scores, hence improving quality of life for 16 weeks.

Downloads

References

Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019; 393(10182): 1745-1759.

https://doi.org/10.1016/s0140-6736(19)30417-9

Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021; 325(6): 568-578.

https://doi.org/10.1001/jama.2020.22171

Su K, Bai Y, Wang J, Zhang H, Liu H, Ma S. Comparison of hyaluronic acid and PRP intra-articular injection with combined intra-articular and intraosseous PRP injections to treat patients with knee osteoarthritis. Clinical Rheumatol. 2018; 37: 1341-1350.

https://doi.org/10.1007/s10067-018-3985-6

Sanchez-Lopez E, Coras R, Torres A, Lane NE, Guma M. Synovial inflammation in osteoarthritis progression. Nat Rev Rheumatol. 2022; 18(5): 258-275. https://doi.org/10.1038/s41584-022-00749-9

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;1; 9(6): 7204.https://doi.org/10.18632/oncotarget.23208

Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011; 7(1): 33-42.

https://doi.org/10.1038/nrrheum.2010.196

Sabha M, Hochberg MC. Non-surgical management of hip and knee osteoarthritis; comparison of ACR/AF and OARSI 2019 and VA/DoD 2020 guidelines. Osteoarthr Cartil Open. 2021; 4(1): 100232. Published 2021 Dec 25.

https://doi.org/10.1016/j.ocarto.2021.100232

Bennell KL, Paterson KL, Metcalf BR, Duong V, Eyles J, Kasza J, et al. Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the RESTORE randomized clinical trial. Jama. 2021; 326(20): 2021-2030.

https://doi.org/10.1001/jama.2021.19415

Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis and cartilage. 2019; 27(11): 1578-1589.

https://doi.org/10.1016/j.joca.2019.06.011

Cheng OT, Souzdalnitski D, Vrooman B, Cheng J. Evidence-based knee injections for the management of arthritis. Pain Med. 2012; 13(6): 740-753.

https://doi.org/10.1111/j.1526-4637.2012.01394.x

Cai Z, Cui Y, Wang J, Qi X, He P, Bu P, et al. A narrative review of the progress in the treatment of knee osteoarthritis. Ann Trans Med. 2022 ; 10(6) 373.

https://doi.org/10.21037/atm-22-818

Han SB, Seo IW, Shin YS. Intra-articular injections of hyaluronic acid or steroids associated with better outcomes than platelet-rich plasma, adipose mesenchymal stromal cells, or placebo in knee osteoarthritis: a network meta-analysis. Arthroscopy. 2021; 37(1): 292-306.

https://doi.org/10.1016/j.arthro.2020.03.041

Maricar N, Parkes MJ, Callaghan MJ, Felson DT, O’Neill TW. Do clinical correlates of knee osteoarthritis predict outcome of intraarticular steroid injections? J Rheumatol. 20201; 47(3): 431-440.

https://doi.org/10.3899/jrheum.180233

Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J,et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis rheumatol. 2020; 72(2): 220-233.

https://doi.org/10.1002/art.41142

Russell SJ, Sala R, Conaghan PG, Habib G, Vo Q, Manning R, et al.Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study. Rheumatol. 2018; 57(12): 2235-41.

https://doi.org/10.1093/rheumatology/key265

Conaghan G, Hunter J, Cohen B, Kraus B, Berenbaum F, Lieberman JR, Jones DG, Spitzer AI, Jevsevar DS, Katz NP, Burgess DJ. Effects of a single intra-articular injection of a microsphere formulation of triamcinolone acetonide on knee osteoarthritis pain: a double-blinded, randomized, placebo-controlled, multinational study. J Bone Joint Surg Am. 2018 ; 100(8): 666-677.

https://doi.org/10.2106/jbjs.17.00154

McAlindon E, LaValley P, Harvey F, Price L, Driban B, Zhang M, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017; 317(19): 1967-1975.

https://doi.org/10.1001/jama.2017.5283

Deyle D, Allen S, Allison C, Gill W, Hando R, Petersen J, et al. Physical therapy versus glucocorticoid injection for osteoarthritis of the knee. N Engl J Med. 2020; 382(15): 1420-1429.

https://doi.org/10.1056/nejmoa1905877

Osani MC, Bannuru RR. Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis. Korean j intern Med. 2019;34(5):966.

https://doi.org/10.3904/kjim.2018.460

Kroon P, Kortekaas C, Boonen A, Böhringer S, Reijnierse M, Rosendaal R,et al. Results of a 6-week treatment with 10 mg Prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial. Lancet. 2019; 394(10213): 1993-2001.

https://doi.org/10.1016/s0140-6736(19)32489-4